FDA — authorised 31 October 1949
- Application: NDA006002
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: ARALEN
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Chloroquine (CQ) on 31 October 1949
Yes. FDA authorised it on 31 October 1949.
SANOFI AVENTIS US holds the US marketing authorisation.